Alkermes (ALKS) Tops Q2 EPS by 7c, Updates FY Guidance

Alkermes (NASDAQ: ALKS) reported Q2 EPS of $0.06, $0.07 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $247.5 million versus the consensus estimate of $232.75 million.

GUIDANCE:

Alkermes sees FY2020 EPS of $0.00-$0.19, versus the consensus of ($0.01). Alkermes sees FY2020 revenue of $965-1005 million, versus the consensus of $983 million.

For earnings history and earnings-related data on Alkermes (ALKS) click here.

You May Also Be Interested In

• United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
• Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
• HSBC explains why risk assets continue to ignore every negative catalyst